美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Global Partners Lp

43.88

+1.784.23%

盤後：43.880.00000.00%16:10 EDT

成交量：4.70萬

成交額：204.06萬

市值：14.92億

市盈率：20.80

高：44.43

開：42.70

低：42.00

收：42.10

52周最高：56.59

52周最低：39.58

股本：3,399.56萬

流通股本：2,767.42萬

量比：0.79

換手率：0.17%

股息：2.99

股息率：6.81%

每股收益(TTM):2.11

每股收益(LYR):2.11

淨資產收益率：14.08%

總資產收益率：3.79%

市淨率：2.49

市盈率(LYR):20.80

資料載入中...

總覽公司新聞資訊公告

華東醫藥：HDM1002作為具有差異化的口服GLP-1靶向藥物，其定位正是為了滿足全球市場未滿足和差異化的臨床需求

羅氏宣佈GLP-1/GIP雙受體藥物二期臨床試驗取得積極結果

环球市场播报

歌禮制藥-B(01672)宣佈口服小分子GLP-1R激動劑ASC30治療糖尿病的13周美國II期研究完成首批受試者給藥

當減肥藥影響航司成本：GLP-1還是不是一個「普通賽道」？

昭衍新藥：公司具備OECD的GLP認證資格，可以承接相關非臨床服務項目

歌禮制藥-B(01672)：歌禮選定新一代每月一次皮下注射GLP-1R/GIPR/GCGR 三靶點激動劑多肽ASC37進行臨床開發

淨利潤預增超200％，聖諾生物借GLP-1減肥賽道大口「吃肉」

华夏时报网

做難而正確的事：藥明康德(02359)為24款GLP-1藥物提供支持滿足最迫切臨床需求

3年5款獲批！國內GLP-1類減肥藥爆發式增長，臨床規範、個性化用藥成挑戰

每日经济新闻

阿斯利康GLP-1減肥藥二期數據將公布

開1支藥給近2元好處費，國家醫保局重拳出擊，「GLP-1牛股」常山藥業推廣服務商賄賂醫生曝光

2026年了，GLP-1還值得投資嗎？

從精打細算的消費者到GLP-1藥物影響，艾伯森CEO稱超市行業面臨艱難一年

GLP-1外溢、AI賦能……生物醫藥會是2026年科技股的「替代品」嗎？

华尔街见闻

1億美元！碩迪生物授權羅氏GLP-1專利

医药魔方Info

2026年多款GLP-1 減肥新藥將上市，消費習慣也將迎來全新變革

环球市场播报

【跨年重磅】專利勝訴！諾和諾德GLP-1雙喜臨門築高牆

石藥集團(01093)：GLP -1 / GIP受體雙偏向性激動多肽注射液(SYH2069注射液)在中國獲臨床試驗批准

進口GLP-1減肥藥價格腰斬：司美格魯肽、替爾泊肽集體降價

「全球藥王」替爾泊肽降價之後：GLP-1進入以價換量時代，線上平台成關鍵變量

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GLP/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners Lp","latestPrice":43.88,"timestamp":1775073600000,"preClose":42.1,"halted":0,"volume":46985,"hourTrading":{"tag":"盘后","latestPrice":43.88,"preClose":43.88,"latestTime":"16:10 EDT","volume":2472,"amount":108471.154824,"timestamp":1775074204733,"change":0,"changeRate":0,"amplitude":0.000228},"delay":0,"changeRate":0.04228028503562948,"floatShares":27674174,"shares":33995563,"eps":2.11,"marketStatus":"盤後交易","change":1.78,"latestTime":"04-01 18:08:41 EDT","open":42.7,"high":44.43,"low":42,"amount":2040611.0448,"amplitude":0.05772,"askPrice":44.75,"askSize":44,"bidPrice":43.03,"bidSize":46,"shortable":3,"etf":0,"ttmEps":2.11,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1775088000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":42.1,"dividendRate":0.06812,"postHourTrading":{"tag":"盘后","latestPrice":43.88,"preClose":43.88,"latestTime":"16:10 EDT","volume":2472,"amount":108471.154824,"timestamp":1775074204733,"change":0,"changeRate":0,"amplitude":0.000228},"volumeRatio":0.793558,"impliedVol":0.2658,"impliedVolPercentile":0.2709},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27674174,"roa":"3.79%","roe":"14.08%","lyrEps":2.11,"volumeRatio":0.793558,"shares":33995563,"dividePrice":2.9891,"high":44.43,"amplitude":0.05772,"preClose":42.1,"low":42,"week52Low":39.58,"pbRate":"2.49","psRate":"0.08","week52High":56.59,"institutionHeld":0.48,"latestPrice":43.88,"committee":0.022222,"eps":2.11,"divideRate":0.06812,"volume":46985,"delay":0,"ttmEps":2.11,"open":42.7,"prevYearClose":41.85,"prevWeekClose":44.37,"prevMonthClose":42.1,"prevQuarterClose":42.1,"fiveDayClose":45.11,"twentyDayClose":48.24,"sixtyDayClose":42.97,"dividendPayoutRate":1.4047537053315338,"dividendFrequency":"Q","dividendGrowthYears":1,"dividendGrowthRate":0.045454545454545574,"fiveYearAvgDividendRate":0.07675548971847668},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-27","symbol":"GLP","fiscalQuarterEnding":"2025/12","expectedEps":0.6,"name":null,"time":"盤前","type":"earning","dateTimestamp":1772168400000,"reportTimeType":"pre","actualEps":0.54},{"date":"2026-02-09","symbol":"GLP","amount":0.76,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-09","defaultRemindTime":1770647400000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-13","payableDate":"2026-02-09","currency":"USD","dateTimestamp":1770613200000,"payDate":"2026-02-13"},{"date":"2025-11-10","symbol":"GLP","amount":0.755,"announcedDate":"2025-10-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-10","defaultRemindTime":1762785000000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-14","payableDate":"2025-11-10","currency":"USD","dateTimestamp":1762750800000,"payDate":"2025-11-14"},{"market":"US","date":"2025-11-07","symbol":"GLP","fiscalQuarterEnding":"2025/09","expectedEps":1.09,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":0.66},{"date":"2025-08-08","symbol":"GLP","amount":0.75,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-08","defaultRemindTime":1754659800000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-08-08","currency":"USD","dateTimestamp":1754625600000,"payDate":"2025-08-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-08-04","recordDate":"2016-08-08","paymentDate":"2016-08-12","value":0.4625,"currency":"USD"},{"executeDate":"2016-11-04","recordDate":"2016-11-08","paymentDate":"2016-11-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-02-07","recordDate":"2017-02-09","paymentDate":"2017-02-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-05-08","recordDate":"2017-05-10","paymentDate":"2017-05-15","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741060800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2026-03-31","current":20.796209,"percent":0.783307,"low":2.771386,"twenty":4.440923,"median":13.153003,"eighty":18.235164,"high":29.34912,"avg":12.375187,"sd":6.522058,"marketCap":1431648296},"quantilePoints":[{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456},{"date":"2025-06-13","current":16.520424,"twenty":4.444767,"median":9.80686,"eighty":15.572999,"marketCap":1905779645},{"date":"2025-06-20","current":16.170677,"twenty":4.440923,"median":9.804164,"eighty":15.627805,"marketCap":1865433127},{"date":"2025-06-27","current":15.57111,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1796267668},{"date":"2025-07-03","current":15.479999,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1785757230},{"date":"2025-07-11","current":15.432974,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1780332488},{"date":"2025-07-18","current":14.992116,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1729475533},{"date":"2025-07-25","current":15.333047,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1768804912},{"date":"2025-08-01","current":15.430035,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1779993442},{"date":"2025-08-08","current":17.700627,"twenty":4.440923,"median":9.82349,"eighty":15.67238,"marketCap":1703526003},{"date":"2025-08-15","current":17.97186,"twenty":4.440923,"median":9.917298,"eighty":15.726991,"marketCap":1729629785},{"date":"2025-08-22","current":17.975383,"twenty":4.440923,"median":9.97212,"eighty":15.765277,"marketCap":1729968795},{"date":"2025-08-29","current":18.669318,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"marketCap":1796753795},{"date":"2025-09-05","current":18.391039,"twenty":4.437079,"median":10.161405,"eighty":15.873833,"marketCap":1769971993},{"date":"2025-09-12","current":18.229004,"twenty":4.440923,"median":10.244717,"eighty":15.951577,"marketCap":1754377526},{"date":"2025-09-19","current":17.911977,"twenty":4.440923,"median":10.348339,"eighty":16.07924,"marketCap":1723866612},{"date":"2025-09-26","current":17.668924,"twenty":4.440923,"median":10.483035,"eighty":16.238322,"marketCap":1700474912},{"date":"2025-10-03","current":16.622738,"twenty":4.440923,"median":10.565798,"eighty":16.310589,"marketCap":1599788897},{"date":"2025-10-10","current":15.678704,"twenty":4.440923,"median":10.601474,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-10-17","current":15.460308,"twenty":4.440923,"median":10.638631,"eighty":16.329708,"marketCap":1487915548},{"date":"2025-10-24","current":16.192991,"twenty":4.440923,"median":10.724558,"eighty":16.329708,"marketCap":1558429659},{"date":"2025-10-31","current":15.978118,"twenty":4.440923,"median":10.745006,"eighty":16.329708,"marketCap":1537750040},{"date":"2025-11-07","current":15.678704,"twenty":4.440923,"median":10.777877,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-11-14","current":18.215203,"twenty":4.440923,"median":10.808766,"eighty":16.403793,"marketCap":1432862540},{"date":"2025-11-21","current":18.438808,"twenty":4.440923,"median":10.856288,"eighty":16.560326,"marketCap":1450451976},{"date":"2025-11-28","current":18.911819,"twenty":4.440923,"median":10.868211,"eighty":16.63112,"marketCap":1487660399},{"date":"2025-12-05","current":19.647135,"twenty":4.440923,"median":10.912667,"eighty":16.757487,"marketCap":1545502583},{"date":"2025-12-12","current":19.023621,"twenty":4.440923,"median":10.960835,"eighty":17.137473,"marketCap":1496455117},{"date":"2025-12-19","current":18.228104,"twenty":4.440923,"median":11.01485,"eighty":17.334253,"marketCap":1433877315},{"date":"2025-12-26","current":18.425908,"twenty":4.440923,"median":11.091519,"eighty":17.554114,"marketCap":1449437201},{"date":"2026-01-02","current":17.995898,"twenty":4.440923,"median":11.134288,"eighty":17.640744,"marketCap":1415611362},{"date":"2026-01-09","current":18.017399,"twenty":4.440923,"median":11.163158,"eighty":17.676428,"marketCap":1417302654},{"date":"2026-01-16","current":19.488032,"twenty":4.440923,"median":11.24834,"eighty":17.766657,"marketCap":1532987023},{"date":"2026-01-23","current":19.139724,"twenty":4.440923,"median":11.32675,"eighty":17.850054,"marketCap":1505588093},{"date":"2026-01-30","current":20.571656,"twenty":4.440923,"median":11.753419,"eighty":17.910997,"marketCap":1618228137},{"date":"2026-02-06","current":20.33085,"twenty":4.440923,"median":12.428533,"eighty":17.953744,"marketCap":1599285667},{"date":"2026-02-13","current":20.812461,"twenty":4.440923,"median":12.525152,"eighty":17.974678,"marketCap":1637170607},{"date":"2026-02-20","current":20.851162,"twenty":4.440923,"median":12.588448,"eighty":17.999212,"marketCap":1640214933},{"date":"2026-02-27","current":20.799561,"twenty":4.440923,"median":12.709526,"eighty":18.067895,"marketCap":1636155832},{"date":"2026-03-06","current":20.672279,"twenty":4.440923,"median":12.766265,"eighty":18.127559,"marketCap":1637616565},{"date":"2026-03-13","current":20.301456,"twenty":4.440923,"median":12.901358,"eighty":18.151279,"marketCap":1608240762},{"date":"2026-03-20","current":20.668016,"twenty":4.440923,"median":12.995923,"eighty":18.186283,"marketCap":1637278912},{"date":"2026-03-27","current":19.180465,"twenty":4.440923,"median":13.141823,"eighty":18.229004,"marketCap":1519438050},{"date":"2026-03-31","current":18.07226,"twenty":4.440923,"median":13.153003,"eighty":18.235164,"marketCap":1431648296}],"updateTime":1775081321116},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606786830","title":"華東醫藥：HDM1002作為具有差異化的口服GLP-1靶向藥物，其定位正是為了滿足全球市場未滿足和差異化的臨床需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2606786830","media":"证券日报 ","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606786830?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 18:38","pubTimestamp":1769510280,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网讯 1月27日，华东医药在互动平台回答投资者提问时表示，HDM1002作为具有差异化的口服GLP-1靶向药物，其定位正是为了满足全球市场未满足和差异化的临床需求。公司始终秉持开放合作战略，在强化自主研发的同时，积极与全球同行一起探索创新药管线的BD机会。未来如达成明确合作协议，公司将严格按照信息披露规则履行披露义务。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-27/doc-inhitxiw5639046.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-27/doc-inhitxiw5639046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4590","BK0187","BK0175","GLP","BK0196","LU1969619763.USD","000963","BK0209","BK0132","BK0188","BK4144","BK0183","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606204678","title":"羅氏宣佈GLP-1/GIP雙受體藥物二期臨床試驗取得積極結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2606204678","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606204678?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 16:57","pubTimestamp":1769504220,"startTime":"0","endTime":"0","summary":"瑞士制药企业罗氏于本周二宣布，其在研的GLP-1/GIP 双受体激动剂 CT-388用于肥胖治疗的二期临床试验，取得了积极结果。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-27/doc-inhitszy5700505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GLP","BK4144","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606261088","title":"歌禮制藥-B(01672)宣佈口服小分子GLP-1R激動劑ASC30治療糖尿病的13周美國II期研究完成首批受試者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2606261088","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606261088?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 08:21","pubTimestamp":1769386878,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，公司董事会宣布其口服小分子GLP-1受体激动剂ASC30治疗2型糖尿病的美国13周II期研究已完成首批受试者给药。在ASC30用于治疗肥胖或超重的II期研究中，因不良事件导致的总体停药率为4.8%。由歌礼自主研发的ASC30是首款也是唯一一款正在临床研究中的、既可每日一次口服也可每月一次至每季度一次皮下注射的小分子GLP-1R完全偏向激动剂，用于肥胖症、糖尿病及其它代谢疾病的治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1161","GLP","BK4590","BK1515","01477","BK4144","01672","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605442012","title":"當減肥藥影響航司成本：GLP-1還是不是一個「普通賽道」？","url":"https://stock-news.laohu8.com/highlight/detail?id=2605442012","media":"世易药研","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605442012?lang=zh_tw&edition=fundamental","pubTime":"2026-01-23 09:44","pubTimestamp":1769132697,"startTime":"0","endTime":"0","summary":"近日，一则跨界新闻在医药圈和航空圈同时炸开了锅：据CBS报道，随着GLP-1类减肥药物在美国的普及，乘客体重的整体减轻竟能为航空公司省下巨额成本。在Makary看来，GLP-1的意义并不止于“减重”。临床层面，GLP-1同样进入“精细化竞争”阶段。GLP-1虽然不太可能成为“另一个阿司匹林”，但它可能会成为慢病时代的第一种“系统性干预工具”。GLP-1触及的，是“体重”“代谢状态”“行为模式”这些更接近生活方式与社会结构的问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123100506953dff0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123100506953dff0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","IE00BZ1G4Q59.USD","BK4585","BK4588","NVO","LU1093756325.SGD","BK4532","BK4144","LU1093756168.USD","IE00BKVL7J92.USD","BK4590","LU0154236417.USD","GLP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2604192180","title":"昭衍新藥：公司具備OECD的GLP認證資格，可以承接相關非臨床服務項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2604192180","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604192180?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 19:09","pubTimestamp":1768907385,"startTime":"0","endTime":"0","summary":"证券日报网讯1月20日，昭衍新药在互动平台回答投资者提问时表示，公司具备OECD的GLP认证资质，可以承接相关非临床服务项目，但来自欧盟地区的收入占比极低，不构成重要影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601203624853333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4144","BK1141","BK4590","BK0216","BK1576","603127","GLP","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604019955","title":"歌禮制藥-B(01672)：歌禮選定新一代每月一次皮下注射GLP-1R/GIPR/GCGR 三靶點激動劑多肽ASC37進行臨床開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2604019955","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604019955?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 17:54","pubTimestamp":1768902869,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，董事会宣布其已选定新一代每月一次皮下给药的 GLP-1R/GIPR/GCGR三靶点激动剂多肽ASC37注射剂作为临床开发候选药物。体外实验显示，在对GLP-1R、GIPR和GCGR的激动活性方面，ASC37比 retatrutide平均分别强约5倍、4倍和4倍。歌礼计划将GLP-1R/ GIPR/GCGR三靶点激动剂多肽ASC37与其每月一次皮下给药的胰淀素受体激动剂多肽ASC36联用，治疗肥胖症、糖尿病以及其它代谢疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GLP","BK1161","BK1515","BK1191","01672","BK4144","GIPR","BK4160","BK4590","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603986959","title":"淨利潤預增超200％，聖諾生物借GLP-1減肥賽道大口「吃肉」","url":"https://stock-news.laohu8.com/highlight/detail?id=2603986959","media":"华夏时报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603986959?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 19:02","pubTimestamp":1768561320,"startTime":"0","endTime":"0","summary":"2026年1月15日晚间，成都圣诺生物科技股份有限公司发布2025年度业绩预告。供需矛盾凸显　　GLP-1类药物减肥适应症的突破，成为引爆全球市场的关键，推动其需求从医疗场景延伸至消费市场。　　综合来看，圣诺生物2025年的业绩高增长，是其精准抓住GLP-1全球供应链机遇的结果，具有明显的周期性和结构性特征。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-16/doc-inhhnzat5490220.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-16/doc-inhhnzat5490220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688117","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603252636","title":"做難而正確的事：藥明康德(02359)為24款GLP-1藥物提供支持 滿足最迫切臨床需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2603252636","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603252636?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 08:36","pubTimestamp":1768437386,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2026年1月14日，药明康德在第44届摩根大通医疗健康大会上公布了其GLP-1类药物管线的最新进展。公司表示，目前公司正为24种GLP-1药物提供支持。根据药明康德所披露的数据显示，截至目前，公司正在研发24款GLP-1药物，涵盖小分子与多肽两类技术路径。持续多年GLP-1类药物短缺或许暴露出核心药品供应链存在不足，这些药物的需求呈现指数级增长，实属历史罕见。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0320764599.SGD","LU1808992512.USD","LU2495084118.USD","LU1046422090.SGD","BK4144","603259","LU0708995583.HKD","LU1997245177.USD","LU1934453819.USD","LU1979443071.USD","LU2328871848.SGD","BK1576","LU1997244956.HKD","LU2045819591.USD","BK0216","GLP","LU1969619763.USD","LU0052750758.USD","BK1583","BK1141","BK4590","LU1997245094.SGD","LU2125910500.SGD","02359","LU2488822045.USD","LU0456842615.SGD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603910456","title":"3年5款獲批！國內GLP-1類減肥藥爆發式增長，臨床規範、個性化用藥成挑戰","url":"https://stock-news.laohu8.com/highlight/detail?id=2603910456","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603910456?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 17:33","pubTimestamp":1768383229,"startTime":"0","endTime":"0","summary":"中国正迎来减肥药爆发期。过去三年，5款GLP-1类减肥药相继在中国获批，叠加上百种在研药物储备，让前几年司美格鲁肽在减重领域的超适应证使用迅速成为历史。但随着药物种类快速扩容，临床规范、个性化用药的挑战逐渐显现。近日，“玛仕度肽Dreams系列研究成果研讨会”在北京举办。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601143619040682.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601143619040682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","BK4590","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603465618","title":"阿斯利康GLP-1減肥藥二期數據將公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2603465618","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603465618?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 01:38","pubTimestamp":1768325884,"startTime":"0","endTime":"0","summary":"2026年1月14日，阿斯利康首席财务官表示，公司GLP-1减肥药的第二阶段临床试验数据预计将在今年内发布。该药物目前正处于研发关键阶段，旨在拓展公司在代谢疾病领域的布局。此次数据公布时间未具体说明，但预计将对后续研发及市场预期产生重要影响。阿斯利康正持续推进相关临床研究，以验证其安全性和有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114014116a716bd3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114014116a716bd3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LU0109394709.USD","LU2417539215.USD","LU2456880835.USD","LU0320765992.SGD","LU1829250122.USD","BK4585","BK4144","LU2462157665.USD","LU2236285917.USD","BK4568","AZN","BK4588","LU0889565916.HKD","BK4590","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602594802","title":"開1支藥給近2元好處費，國家醫保局重拳出擊，「GLP-1牛股」常山藥業推廣服務商賄賂醫生曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2602594802","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602594802?lang=zh_tw&edition=fundamental","pubTime":"2026-01-12 15:45","pubTimestamp":1768203939,"startTime":"0","endTime":"0","summary":"对应时段内上述医生共开具万脉宁18275支。由此推算，推广服务商开1支药给医生约1.92回扣。天眼查信息显示，常山药业成立于2000年9月28日。此次通报中，国家医保局明确指出，医药商业贿赂本质上是通过给予不正当利益影响处方权，干扰正常诊疗行为，妨碍公平竞争，加重医药负担，使得医药产品销售从实际临床价值和产品的竞争力转为以高返点和高回扣驱动的不当竞争。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1768203842807948351","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","GLP","BK0070","BK4590","BK0172","300255","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602342912","title":"2026年了，GLP-1還值得投資嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2602342912","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602342912?lang=zh_tw&edition=fundamental","pubTime":"2026-01-09 14:37","pubTimestamp":1767940623,"startTime":"0","endTime":"0","summary":"文｜锦缎2026年的GLP-1赛道，正站在命运转折的关键路口。与此同时，国内药企也在口服GLP-1赛道全力追赶。2026年，随着更多口服GLP-1制剂的陆续上市，该品类将正式完成从“治疗型”向“管理型”的战略转型，进一步打开轻症预防与长期体重管理的增量市场空间。在2025年，礼来密集启动了三项Bimagrumab与替尔泊肽联用的临床试验，包括健康人群的生物利用度测试以及肥胖合并糖尿病患者的Ⅱ期研究，试图验证“GLP-1+ActRII”联合方案的减脂增肌效果。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1767926581826072934","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4590","BK4144","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126922535","title":"從精打細算的消費者到GLP-1藥物影響，艾伯森CEO稱超市行業面臨艱難一年","url":"https://stock-news.laohu8.com/highlight/detail?id=1126922535","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126922535?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 04:36","pubTimestamp":1767818185,"startTime":"0","endTime":"0","summary":"艾伯森公司首席执行官苏珊·莫里斯坦言，2026年的食品零售商正面临严峻挑战。莫里斯在接受采访时指出，包括艾伯森在内的超市企业必须在应对消费者对价格上涨敏感度的同时，妥善处理自身在工资和公用事业费用等方面的成本攀升问题。消费者的超市购物支出还受到多重因素制约：物价上涨促使精打细算的顾客缩减购物量，而GLP-1减肥药物的使用者正在改变其购买品类和数量。在第三财季，艾伯森销售额微增2%至191.2亿美元，略低于华尔街预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK4144","ACI","BK4590","BK4113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601878793","title":"GLP-1外溢、AI賦能……生物醫藥會是2026年科技股的「替代品」嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2601878793","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601878793?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 15:40","pubTimestamp":1767771620,"startTime":"0","endTime":"0","summary":"花旗表示，GLP-1适应症从减重外溢至心血管和神经系统，并将迎来Medicare支付扩容与礼来口服药orforglipron上市；AI在研发、生产和临床环节全面兑现成本与效率收益；加之DTP（直面患者）模式对分销渠道的重塑，行业整体盈利质量和创新转化效率正得到显著提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3762729","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3762729","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK1147","BK4590","161726","GLP","03086","399441","TTTN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601127868","title":"1億美元！碩迪生物授權羅氏GLP-1專利","url":"https://stock-news.laohu8.com/highlight/detail?id=2601127868","media":"医药魔方Info","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601127868?lang=zh_tw&edition=fundamental","pubTime":"2026-01-06 15:41","pubTimestamp":1767685313,"startTime":"0","endTime":"0","summary":"2025年12月30日，Structure Therapeutics通过其子公司Gasherbrum Bio与罗氏和基因泰克达成了一项非独家专利许可协议，并获得了1亿美元的预付款。若一方出现重大违约且未能纠正，或基因泰克对授权专利的有效性提出质疑，硕迪生物均有权终止本协议。这笔1亿美元的现金注入，为硕迪生物带来了非稀释性资金，可助力其在竞争激烈的GLP-1赛道推进临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106155205a4a258bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106155205a4a258bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GLP","GPCR","BK4144","BK4599","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600069188","title":"2026年多款GLP-1 減肥新藥將上市，消費習慣也將迎來全新變革","url":"https://stock-news.laohu8.com/highlight/detail?id=2600069188","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600069188?lang=zh_tw&edition=fundamental","pubTime":"2026-01-02 23:11","pubTimestamp":1767366660,"startTime":"0","endTime":"0","summary":"　　这股涟漪，即将掀起巨浪。　　当前，有意通过 GLP-1 类药物治疗肥胖症的人群仍面临诸多阻碍。　　迈入 2026 年，这些阻碍正逐步破除。药品价格持续走低，医保覆盖范围不断扩大，口服剂型药物也有望正式上市。这意味着，使用 GLP-1 类药物的人群规模即将大幅激增。这对公共卫生领域而言是重大利好，同时也将深刻重塑消费者习惯，为投资者创造全新机遇。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-02/doc-inhexwhi4285403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GLP","BK4590","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600870666","title":"【跨年重磅】專利勝訴！諾和諾德GLP-1雙喜臨門築高牆","url":"https://stock-news.laohu8.com/highlight/detail?id=2600870666","media":"药见未来","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600870666?lang=zh_tw&edition=fundamental","pubTime":"2026-01-01 02:30","pubTimestamp":1767205806,"startTime":"0","endTime":"0","summary":"一是口服版Wegovy在美国获批上市，二是司美格鲁肽在中国赢得专利终审胜诉。这两大事件不仅是诺和诺德的胜利，更是全球GLP-1市场格局的分水岭。中国市场的重要性：专利胜诉意味着中国作为全球最具增长潜力的肥胖症市场，将在未来几年内持续为诺和诺德贡献稳健的现金流，这对其全球化布局具有定海神针的作用。诺和诺德的跨年双喜临门，不仅是其自身商业版图的扩张，更预示着一个更加便捷、合规、多元的减重时代已经到来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101030815a48f94df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101030815a48f94df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","BK4599","GLP","LU1093756168.USD","BK4588","BK4532","BK4585","BK4590","LU0154236417.USD","BK4144","BK4007"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2595813917","title":"石藥集團(01093)：GLP -1 / GIP受體雙偏向性激動多肽注射液(SYH2069注射液)在中國獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2595813917","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595813917?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 18:24","pubTimestamp":1767003869,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的GLP -1 / GIP受体双偏向性激动多肽注射液已获得中华人民共和国国家药品监督管理局批准，可在中国开展临床试验。非人灵长类重复给药毒理研究显示，该产品耐受性良好，未观察到任何呕吐及胃肠道不良反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008369823.USD","IE00BZ08YR35.GBP","LU1807302812.USD","LU0315179316.USD","IE00B543WZ88.USD","LU0067412154.USD","IE00B5MMRT66.SGD","LU0880133367.SGD","01093","LU1226287529.USD","LU1226288253.USD","LU1951186391.HKD","BK4590","LU0501845795.SGD","LU1152091168.USD","LU0326950275.SGD","BK1515","IE0008368742.USD","IE00B031HY20.USD","LU1960683339.HKD","GLP","HK0000165453.HKD","LU1993786604.SGD","LU0140636845.USD","LU0314109678.HKD","LU1226287875.USD","BK1521","LU2039709279.SGD","LU1328277881.USD","SG9999004220.SGD","LU0072913022.USD","BK4144","BK1191","IE00BZ08YT58.USD","LU1008478684.HKD","LU1813983027.USD","IE00BZ08YS42.EUR","LU1226287792.SGD","LU1152091754.HKD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595070782","title":"進口GLP-1減肥藥價格腰斬：司美格魯肽、替爾泊肽集體降價","url":"https://stock-news.laohu8.com/highlight/detail?id=2595070782","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595070782?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 15:38","pubTimestamp":1766993896,"startTime":"0","endTime":"0","summary":"曾经一支难求的进口GLP-1减肥药，现在已进入降价通道了。近日，在云南省药品集中采购平台和四川省药械招标采购服务中心上，都出现了进口减肥药司美格鲁肽（商品名：诺和盈）注射液降价信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512293604395562.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512293604395562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4144","BK4590","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595207840","title":"「全球藥王」替爾泊肽降價之後：GLP-1進入以價換量時代，線上平台成關鍵變量","url":"https://stock-news.laohu8.com/highlight/detail?id=2595207840","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595207840?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 14:56","pubTimestamp":1766991395,"startTime":"0","endTime":"0","summary":"【“全球药王”替尔泊肽降价之后：GLP-1进入以价换量时代，线上平台成关键变量】在国内减重与降糖药市场，新晋“全球药王”替尔泊肽的价格松动，比多数人预期得更早。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512293604378545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","BK4144","BK4590"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":93,"code":"91000000","status":"200"}]}}